Clomethiazole
featured

Notice: hodoodo.ccom website will be shut down by June 30, 2025. Its business will be taken care by MedKoo Bioscience. Please visit medkoo.com for your research need.

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H562313

CAS#: 533-45-9 (free base)

Description: Clomethiazole is a positive allosteric modulator at the barbiturate/picrotoxin site of the GABAA receptor. It acts as a sedative and hypnotic agent.

Chemical Structure

img
Clomethiazole
CAS# 533-45-9 (free base)
Instruction

Theoretical Analysis

Hodoodo Cat#: H562313
Name: Clomethiazole
CAS#: 533-45-9 (free base)
Chemical Formula: C6H8ClNS
Exact Mass: 161.01
Molecular Weight: 161.640
Elemental Analysis: C, 44.58; H, 4.99; Cl, 21.93; N, 8.67; S, 19.83

Price and Availability

Size Price Availability Quantity
10mg USD 285 2 Weeks
50mg USD 650 2 Weeks
100mg USD 1050 2 Weeks
Bulk inquiry

Related CAS #: 1867-58-9 (edisylate)   533-45-9 (free base)   6001-74-7 (HCl)  

Synonym: Clomethiazole; Chlormethiazole;

IUPAC/Chemical Name: 5-(2-Chloroethyl)-4-methyl-1,3-thiazole

InChi Key: PCLITLDOTJTVDJ-UHFFFAOYSA-N

InChi Code: InChI=1S/C6H8ClNS/c1-5-6(2-3-7)9-4-8-5/h4H,2-3H2,1H3

SMILES Code: CC1=C(CCCl)SC=N1

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 161.64 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Karsy M, Brock A, Guan J, Taussky P, Kalani MY, Park MS. Neuroprotective strategies and the underlying molecular basis of cerebrovascular stroke. Neurosurg Focus. 2017 Apr;42(4):E3. doi: 10.3171/2017.1.FOCUS16522. Review. PubMed PMID: 28366066.

2: Liu J, Wang LN, Ma X, Ji X. Gamma aminobutyric acid (GABA) receptor agonists for acute stroke. Cochrane Database Syst Rev. 2016 Oct 4;10:CD009622. Review. PubMed PMID: 27701753.

3: Busardò FP, Kyriakou C, Napoletano S, Marinelli E, Zaami S. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome. Eur Rev Med Pharmacol Sci. 2015 Dec;19(23):4654-63. Review. PubMed PMID: 26698265.

4: Seitz HK, Mueller S. Alcohol and cancer: an overview with special emphasis on the role of acetaldehyde and cytochrome P450 2E1. Adv Exp Med Biol. 2015;815:59-70. doi: 10.1007/978-3-319-09614-8_4. Review. PubMed PMID: 25427901.

5: Liu J, Wang LN. Gamma aminobutyric acid (GABA) receptor agonists for acute stroke. Cochrane Database Syst Rev. 2014 Aug 6;(8):CD009622. doi: 10.1002/14651858.CD009622.pub3. Review. Update in: Cochrane Database Syst Rev. 2016 Oct 04;10 :CD009622. PubMed PMID: 25097101.

6: Drach LM. [Psychopharmalogical treatment of delirium in the elderly]. Med Monatsschr Pharm. 2014 Apr;37(4):124-31; quiz 133-4. Review. German. PubMed PMID: 24779187.

7: Mainerova B, Prasko J, Latalova K, Axmann K, Cerna M, Horacek R, Bradacova R. Alcohol withdrawal delirium - diagnosis, course and treatment. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Mar;159(1):44-52. doi: 10.5507/bp.2013.089. Epub 2013 Dec 11. Review. PubMed PMID: 24399242.

8: Keating GM. Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence. Clin Drug Investig. 2014 Jan;34(1):63-80. doi: 10.1007/s40261-013-0158-x. Review. PubMed PMID: 24307430.

9: Shorvon S. The historical evolution of, and the paradigms shifts in, the therapy of convulsive status epilepticus over the past 150 years. Epilepsia. 2013 Sep;54 Suppl 6:64-7. doi: 10.1111/epi.12281. Review. PubMed PMID: 24001077.

10: Awissi DK, Lebrun G, Fagnan M, Skrobik Y; Regroupement de Soins Critiques, Réseau de Soins Respiratoires, Québec. Alcohol, nicotine, and iatrogenic withdrawals in the ICU. Crit Care Med. 2013 Sep;41(9 Suppl 1):S57-68. doi: 10.1097/CCM.0b013e3182a16919. Review. PubMed PMID: 23989096.

11: Liu J, Wang LN. Gamma aminobutyric acid (GABA) receptor agonists for acute stroke. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD009622. doi: 10.1002/14651858.CD009622.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;(8):CD009622. PubMed PMID: 23450607.

12: Seitz HK, Wang XD. The role of cytochrome P450 2E1 in ethanol-mediated carcinogenesis. Subcell Biochem. 2013;67:131-43. doi: 10.1007/978-94-007-5881-0_3. Review. PubMed PMID: 23400919.

13: Brünen S, Vincent PD, Baumann P, Hiemke C, Havemann-Reinecke U. Therapeutic drug monitoring for drugs used in the treatment of substance-related disorders: literature review using a therapeutic drug monitoring appropriateness rating scale. Ther Drug Monit. 2011 Oct;33(5):561-72. doi: 10.1097/FTD.0b013e31822fbf7c. Review. PubMed PMID: 21912330.

14: Kolla BP, Mansukhani MP, Schneekloth T. Pharmacological treatment of insomnia in alcohol recovery: a systematic review. Alcohol Alcohol. 2011 Sep-Oct;46(5):578-85. doi: 10.1093/alcalc/agr073. Epub 2011 Jun 29. Review. PubMed PMID: 21715413.

15: Lutz UC, Batra A. [Diagnostics and therapy of alcohol withdrawal syndrome: focus on delirium tremens and withdrawal seizure]. Psychiatr Prax. 2010 Sep;37(6):271-8. doi: 10.1055/s-0030-1248443. Epub 2010 Aug 27. Review. German. PubMed PMID: 20803410.

16: Caputo F, Bernardi M. Medications acting on the GABA system in the treatment of alcoholic patients. Curr Pharm Des. 2010;16(19):2118-25. Review. PubMed PMID: 20482512.

17: Leone MA, Vigna-Taglianti F, Avanzi G, Brambilla R, Faggiano F. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses. Cochrane Database Syst Rev. 2010 Feb 17;(2):CD006266. doi: 10.1002/14651858.CD006266.pub2. Review. PubMed PMID: 20166080.

18: Walter M, Wiesbeck GA. [Pharmacotherapy of substance dependence and withdrawal syndromes]. Ther Umsch. 2009 Jun;66(6):449-57. doi: 10.1024/0040-5930.66.6.449. Review. German. PubMed PMID: 19496041.

19: Bonnet U, Schäfer M, Richter C, Milkereit J, Wiltfang J, Scherbaum N, Lieb B. [Anticonvulsants in the treatment of alcoholism]. Fortschr Neurol Psychiatr. 2009 Apr;77(4):192-202. doi: 10.1055/s-0028-1109214. Epub 2009 Apr 3. Review. German. PubMed PMID: 19347790.

20: Grocott HP. Pharmacologic neuroprotection: the search continues. J Extra Corpor Technol. 2007 Dec;39(4):296-301. Review. PubMed PMID: 18293824; PubMed Central PMCID: PMC4680702.